Search for: "N.D v. M.D."
Results 81 - 100
of 492
Sort by Relevance
|
Sort by Date
16 Jun 2020, 2:18 pm
John Reed StarkIs a company’s post-breach forensic report subject to discovery in subsequent breach related litigation? [read post]
2 Jun 2020, 12:54 am
Inc., No. 17-CV-01506-PJH, 2018 WL 5906075, at *13 (N.D. [read post]
28 May 2020, 8:55 am
Supp. 2d 1324, 1337 (M.D. [read post]
28 May 2020, 8:55 am
Supp. 2d 1324, 1337 (M.D. [read post]
28 May 2020, 8:55 am
Supp. 2d 1324, 1337 (M.D. [read post]
28 May 2020, 8:55 am
Supp. 2d 1324, 1337 (M.D. [read post]
28 May 2020, 8:55 am
Supp. 2d 1324, 1337 (M.D. [read post]
28 May 2020, 5:29 am
Another vacuous response to a methodological challenge under Rule 702 is to label the challenge as “going to the weight, not the admissibility” of the challenged expert witness’s testimony. [read post]
15 May 2020, 3:12 pm
, 2020 WL 2097607 (N.D. [read post]
8 May 2020, 11:00 am
Beckett Gas, Inc., 200 F.R.D. 392, 396 n.3 (M.D. [read post]
5 May 2020, 12:59 pm
Apr. 30, 2020). [5] Complaint, ECF No. 1, 3M Co. v. 1 Ignite Capital, LLC, No. 4:20-cv-00225 (N.D. [read post]
19 Apr 2020, 9:00 am
IMAN365-USA, 2020 WL 977969 (N.D. [read post]
13 Apr 2020, 6:00 am
LEXIS 55107 (M.D. [read post]
30 Mar 2020, 4:59 am
Hart v. [read post]
19 Mar 2020, 10:35 am
Stern v. [read post]
12 Mar 2020, 6:01 pm
Supp. 943, 962 (N.D. [read post]
18 Feb 2020, 9:20 am
M.D. [read post]
15 Feb 2020, 6:56 am
Midas Worthington, LLC, 2020 WL 113350 (M.D. [read post]
23 Jan 2020, 10:37 pm
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
21 Jan 2020, 10:00 pm
LEXIS 13826 (M.D. [read post]